SEC Form 4 · accession 0001209191-15-012243
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew E. Singer
Officer — EVP & CFO
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.49 | Feb 9, 2015 | A | 104,169 | A | — | Feb 8, 2025 | Common Stock | 104,169 | 104,169 | D |
| Restricted Stock UnitF2,F3 | — | Feb 9, 2015 | A | 37,313 | A | — | — | Common Stock | 37,313 | 37,313 | D |
Explanation of responses
- F1This option was granted on February 9, 2015 pursuant to the Company's 2013 Stock Incentive Plan with respect to 104,169 shares of Common Stock, with 25% vesting on February 9, 2016 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
- F2Each restricted stock unit represents the right to receive one share of Epizyme, Inc. common stock upon vesting.
- F3This award, granted on February 9, 2015 pursuant to the Company's Stock Incentive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.